Positron, through its wholly owned subsidiary, Manhattan Isotope Technology (MIT), has executed a memorandum of understanding with the Institute of Nuclear Research (INR) of Troitsk, Russia. MIT and INR will collaborate on strontium-82 production beginning with a pharmaceutical ingredient validation exercise in 2012.

WASHINGTON, D.C.The Society of Thoracic Surgeons-American College of Cardiology (STS-ACC) Transcatheter Valvular Therapy (TVT) Registry, which will track real-life outcomes of implanting transcatheter heart valves, will charge an initiation fee of $25,000 and an annual fee of $10,000 for each year following, STS Past-President Michael J. Mack, MD, told Cardiovascular Business during the Cardiovascular Research Technologies (CRT) meeting this week.

The Healthcare Information and Management Systems Society (HIMSS) announced the winners of its annual leadership awards: Carol Bickford, PhD, RN; Kathleen Smith, MS, RN; and Russell Leftwich, MD.

Revised criteria for the diagnosis of mild cognitive impairment (MCI) could compromise the diagnosis of Alzheimer disease (AD) dementia, according to an analysis published online Feb. 6 in Archives of Neurology.

The Government Accountability Office (GAO) has found that sellers of implantable medical devices are negotiating widely varying prices from different hospitals for the same devices and keeping their pricing strategies a secret. The lack of transparency may have major ramifications for Medicare, as hospitals with less purchasing power pass their costs along.

The Centers for Medicare & Medicaid Services (CMS) announced that its Recovery Audit Prepayment Review Demonstration will move forward by June 1.

Watch for the FDAs Center for Devices & Radiological Health (CDRH) to focus attention on four areas of activity for the remainder of the current year: implementing a total product lifecycle approach, enhancing communication and transparency, strengthening its workforce and workplace, and facilitating innovation and addressing unmet public health needs.

The Massachusetts Life Sciences Center has awarded Bostons Dana-Farber Cancer Institute a $10 million grant to support the expansion of its cancer imaging research program.